olomoucine has been researched along with Astrocytosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Djukic, ND; Jayaseelan, JSP; Muyderman, H; Sims, NR; Woodman, RJ; Yew, WP | 1 |
| Hyun, HW; Kim, JE; Min, SJ | 1 |
| Bu, B; Tian, D; Wang, W; Xie, M; Yu, Z; Zhang, L; Zhang, Q; Zhu, S; Zhu, Z | 1 |
| Dong, Q; He, Y; Pan, DJ; Tian, DS; Wang, W; Xie, MJ; Yu, ZY | 1 |
4 other study(ies) available for olomoucine and Astrocytosis
| Article | Year |
|---|---|
Differential effects of the cell cycle inhibitor, olomoucine, on functional recovery and on responses of peri-infarct microglia and astrocytes following photothrombotic stroke in rats.
Topics: Animals; Astrocytes; Cell Cycle; Disease Models, Animal; Gliosis; Kinetin; Male; Microglia; Motor Cortex; Neurons; Rats; Rats, Sprague-Dawley; Recovery of Function; Stroke | 2021 |
CDK5 inhibitors prevent astroglial apoptosis and reactive astrogliosis by regulating PKA and DRP1 phosphorylations in the rat hippocampus.
Topics: Animals; Apoptosis; Astrocytes; CA1 Region, Hippocampal; Cyclic AMP-Dependent Protein Kinases; Cyclin-Dependent Kinase 5; Dentate Gyrus; Dynamins; Gliosis; Kinetin; Male; Nerve Degeneration; Phosphorylation; Protein Kinase Inhibitors; Purines; Rats; Roscovitine; Status Epilepticus | 2017 |
Inhibiting cell cycle progression reduces reactive astrogliosis initiated by scratch injury in vitro and by cerebral ischemia in vivo.
Topics: Analysis of Variance; Animals; Astrocytes; Brain Injuries; Brain Ischemia; Cell Cycle; Cell Death; Cells, Cultured; Cyclin D1; Disease Models, Animal; Enzyme Inhibitors; Gliosis; Ki-67 Antigen; Kinetin; Male; Mice; Mice, Knockout; Middle Cerebral Artery; Rats; Rats, Wistar; Statistics, Nonparametric; Wounds and Injuries | 2007 |
Attenuation of astrogliosis by suppressing of microglial proliferation with the cell cycle inhibitor olomoucine in rat spinal cord injury model.
Topics: Analysis of Variance; Animals; CD11b Antigen; Cell Proliferation; Disease Models, Animal; Enzyme Inhibitors; Female; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Gliosis; Ki-67 Antigen; Kinetin; Microglia; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spinal Cord Injuries; Time Factors | 2007 |